A case of hypothyroidism and type 2 diabetes associated with type V hyperlipoproteinemia and eruptive xanthomas

J Korean Med Sci. 2005 Jun;20(3):502-5. doi: 10.3346/jkms.2005.20.3.502.

Abstract

Primary hypothyroidism and type 2 diabetes are both typically associated with the increased level of triglycerides. To date, there have been only a few case reports of type 2 diabetes patients with both type V hyperlipoproteinemia and eruptive xanthomas, but there have been no reports of hypothyroidism patients associated with eruptive xanthomas. We report here on a case of a 48-yr old female patient who was diagnosed with type 2 diabetes and primary hypothyroidism associated with both type V hyperlipoproteinemia and eruptive xanthomas. We found rouleaux formation of RBCs in peripheral blood smear, elevated TSH, and low free T4 level, and dyslipidemia (total cholesterol 18.1 mM/L, triglyceride 61.64 mM/L, HDL 3.0 mM/L, and LDL 2.54 mM/L). She has taken fenofibrate, levothyroxine, and oral hypoglycemic agent for 4 months. After treatment, both TSH level and lipid concentration returned to normal range, and her yellowish skin nodules have also disappeared.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Erythrocyte Aggregation
  • Female
  • Fenofibrate / therapeutic use
  • Humans
  • Hyperlipidemias / blood
  • Hyperlipoproteinemia Type V / blood
  • Hyperlipoproteinemia Type V / complications*
  • Hyperlipoproteinemia Type V / drug therapy
  • Hypoglycemic Agents / therapeutic use
  • Hypolipidemic Agents / therapeutic use
  • Hypothyroidism / blood
  • Hypothyroidism / complications*
  • Hypothyroidism / drug therapy
  • Middle Aged
  • Skin Diseases / blood
  • Skin Diseases / complications
  • Skin Diseases / drug therapy
  • Thyrotropin / blood
  • Thyrotropin / therapeutic use
  • Thyroxine / blood
  • Treatment Outcome
  • Xanthomatosis / blood
  • Xanthomatosis / complications*
  • Xanthomatosis / drug therapy

Substances

  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Thyrotropin
  • Thyroxine
  • Fenofibrate